title: Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumor lysis in a patient with peripheral T-cell lymphoma unspecified.
authors: Yuji
authors: Y
authors: Hirata
authors: Taiji
authors: T
authors: Yokote
authors: Kichinosuke
authors: K
authors: Kobayashi
authors: Shoko
authors: S
authors: Nakayama
authors: Takuji
authors: T
authors: Miyoshi
authors: Toshikazu
authors: T
authors: Akioka
authors: Motomu
authors: M
authors: Tsuji
authors: Takayuki
authors: T
authors: Takubo
authors: Toshiaki
authors: T
authors: Hanafusa
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced / Q000175:diagnosis* / Q000209:etiology*; D016411:Lymphoma, T-Cell, Peripheral / Q000188:drug therapy*; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use; D011379:Prognosis; D012008:Recurrence; D016896:Treatment Outcome; D015275:Tumor Lysis Syndrome / Q000150:complications*; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone